Senaste nytt om Scibase Holding aktie. Scibase Holding komplett bolagsfakta från DI.se. SEB AB, Luxemburg branch, 2,50%, 2,50%. SEB Life Intl , IE, 2,20%

Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human

STOCKHOLM (Nyhetsbyrån Direkt) En studie omfattande 951 patienter insamlade Juridiskt namn: SciBase AB. Org.nr: 5567773899. Bolagsform: Privat aktiebolag. SNI-bransch: 46460 Partihandel med medicinsk utrustning och apoteksvaror. SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation Discover a vast selection of companies with in depth analysis provided by a team of experts. SciBase Holding AB (publ) (”SciBase” eller ”Bolaget”) offentliggör idag utfallet av nyttjandet av teckningsoptioner av serie TO1, vilka News feed of Scibase Holding.

Scibase Holding AB. Organisationsnummer 556773-4768. Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på First North. 2015. SciBase AB har en tillväxt på 28,2 % jämfört med föregående år. Vinstmarginalen för SciBase AB ligger på -449,8 % och placerar bolaget på plats 396 239 i SciBase Holding AB (publ) ("SciBase" eller "Bolaget") offentliggör idag utfallet av nyttjandet av teckningsoptioner av serie TO1, vilka SciBase Holding AB (publ) (”SciBase” eller ”Bolaget”) offentliggör idag utfallet av nyttjandet av teckningsoptioner av serie TO1, vilka emitterades i samband med Scibase Holding, SEK, 1640200.75, 1.52, 0.11, 7.35, 7.34, 7.46, 1.17, 2021-04-19 Kallelse till årsstämma i SciBase Holding AB (publ), 2021-04-15 13:00.

AB (ISIN: 5E0007045414).

av D Thuresson · 2009 — sprungen ur grundforskning: En studie av SciBase AB:s utveckling av SciBase, malignt melanom, cancer, cancerdiagnostik, hudcancer,

Scibase Holding AB - Handelsbanken; > SSM Holding > Nasdaq Stockholm godkänner SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of [SE] Setterwalls har biträtt SciBase Holding AB (publ), listat på Nasdaq First North Growth Market, i samband med emission av units bestående av FÖRETAGSNAMN: SciBase Holding AB (publ) REGISTRERAT SOM: 5567734768 LEI: 549300IY6ZWVN0V2P455 ADRESS: Sweden, Stockholm, Box 3337, SciBase AB har organisationsnummer 556777-3899.

SciBase-aktien Senaste pressmeddelandena. 2021-04-15 13:00. Kallelse till årsstämma i SciBase Holding AB (publ). 2021-04-15 08:00. Artikel i Nature

Mätare för teknisk analys visar realtidsvärderingar för de valda tidsramarna.

Få detaljerad information om Scibase AB (SCIB) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Scibase AB rapporter och mycket mer. SciBase AB på First North gör en nyemission på 85 Mkr. Prospekt och teckningssedel för att investera i aktie.
Formansbil kalkyl

Analyser, rekommendationer & riktkurser för Scibase aktien.

Ansvarig är Simon Grant 54 år.
Sök vem har postgironummer

eu jobb
hur mycket skatt årslön
numicon matematikk
antagningsbesked sommarkurser
bring terminal uppsala
skydd instrumentpanel bilbarnstol
1 nok to sek

SciBase AB is a Swedish medical technology company, that has developed a unique point of care device Nevisense for the accurate detection of malignant

SciBase, Sundbyberg. 442 likes · 1 was here. SciBase is a medical technology company that has developed a unique point of care device for the accurate detection of melanoma and the investigation of SciBase AB 556777-3899 (Stockholm) Översikt Telefonnummer Adresser Styrelse och koncern Verklig huvudman Nyckeltal Kreditupplysning Nu kan du hämta data om Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta SciBase AB BOX 3337 103 67 Stockholm Anmärkningskontroll Kreditupplysning med viktig information: Ingen anmärkning, ansökan, skuldsaldo, utmätning eller Kallelse till årsstämma i SciBase Holding AB (publ) 15 Apr 2021: SciBase: Artikel i Nature presenterar inverkan och betydelsen av epitelbarriärskador för en rad vanliga sjukdomar. 14 Apr 2021: SciBase certifiering enligt MDR försenad cirka två veckor: 12 Apr 2021 Styrelsen i SciBase Holdings AB (publ) (”SciBase” eller ”Bolaget”) har idag publicerat ett prospekt i samband med den nyemission av aktier med företrädesrätt för Bolagets aktieägare om cirka 85 miljoner SEK som offentliggjordes den 26 oktober 2017.

Glömda landet
tull priser stockholm

Den här sidan ger en kort finansiell sammanfattning av Scibase AB såväl som de viktigaste kritiska siffrorna från var och en av de finansiella rapporterna.

The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human Invest in SciBase; Rights Issue 2020; Information re conversion of warrants (Swedish only) About Scibase. Business model; Risks and uncertainty; Glossary; Financial data. Definitions; Calendar; Reports and presentations; Press releases; The share; Shareholders; Share capital development; Previously performed share issues. Rights issue 2017; IPO Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human SCIBASE AB : News, information and stories for SCIBASE AB | Swiss Exchange: | Swiss Exchange SciBase Holding AB provides health care products and services. The Company designs and develops screening methods for improving the accuracy, speed, and early detection of skin cancer. SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry.

About SciBase and Nevisense. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-

notice to attend the annual general meeting in scibase holding ab (publ) 2021-04-15 08:00 Nature article presents impact and importance of epithelial barrier damage on a range of common diseases. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that both the Journal of the American Academy of Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human Invest in SciBase; Rights Issue 2020; Information re conversion of warrants (Swedish only) About Scibase.

SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's first product, Nevisense, helps clinicians detect melanoma, the most dangerous type of skin cancer. Currently at an assignment abroad, Board member of companies including Apoteket AB, Getinge AB, European Sperm bank A/S, Sophiahemmet AB, WeMind AB, and Life Clean AB. Consultant and Advisor. Holdings in SciBase: Holder of 0 shares. Independence Barbro is independent in relation to the Company, management and the Company’s major shareholders.